QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) (OTCQB: TRXD) Announces Nasdaq Uplisting, Pricing of $5.2M Firm Commitment Public Offering, Effectiveness of Reverse Stock Split
Trxade Group (NASDAQ: MEDS) (OTCQB: TRXD), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, this morning announced that its common stock will today begin trading on the Nasdaq Capital Market under the new symbol ‘MEDS’. In connection with the company’s … Continue reading “QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) (OTCQB: TRXD) Announces Nasdaq Uplisting, Pricing of $5.2M Firm Commitment Public Offering, Effectiveness of Reverse Stock Split”